Ethionamide boosters part 2: combining bioisosteric replacement and structure-based drug design to solve pharmacokinetic issues in a series of potent 1,2,4-oxadiazole ethr inhibitors.
PDB DOI: 10.2210/pdb3sdg/pdb
Classification: TRANSCRIPTION REPRESSOR/INHIBITOR Organism(s): Mycobacterium Tuberculosis
Deposited: 2011-06-09 Deposition Author(s): Baulard, A.R. , Blondiaux, N. , Brodin, P. , Christophe, T. , D Prez, B. , Desroses, M. , Flament, M.P. , Flipo, M. , Jeon, H.K. , Lecat-Guillet, N. , Leroux, F. , Locht, C. , Mathys, V. , Piveteau, C. , Siepmann, J. , Soror, S.H. , Villemagne, B. , Villeret, V. , Willand, N. , Wintjens, R. , Wohlkonig, A.
Ethionamide boosters part 2: combining bioisosteric replacement and structure-based drug design to solve pharmacokinetic issues in a series of potent 1,2,4-oxadiazole ethr inhibitors.
Baulard, A.R. , Blondiaux, N. , Brodin, P. , Christophe, T. , D Prez, B. , Desroses, M. , Flament, M.P. , Flipo, M. , Jeon, H.K. , Lecat-Guillet, N. , Leroux, F. , Locht, C. , Mathys, V. , Piveteau, C. , Siepmann, J. , Soror, S.H. , Villemagne, B. , Villeret, V. , Willand, N. , Wintjens, R. , Wohlkonig, A.
Primary Citation of Related Structures: 3SDG
Proteins | ||||
---|---|---|---|---|
Molecule | Chains | Sequence Length | Organism | Sequence |
HTH-type transcriptional regulator EthR | A | 236 | Mycobacterium Tuberculosis | MGSSHHHHHHSSGLVPRGSHMTTSAASQASLPRGRRTARPSGDDRELAILATAENLLEDRPLADISVDDLAKGAGISRPTFYFYFPSKEAVLLTLLDRVVNQADMALQTLAENPADTDRENMWRTGINVFFETFGSHKAVTRAGQAARATSVEVAELWSTFMQKWIAYTAAVIDAERDRGAAPRTLPAHELATALNLMNERTLFASFAGEQPSVPEARVLDTLVHIWVTSIYGENR |
Method: X-RAY DIFFRACTION
Deposited Date: 2011-06-09 Deposition Author(s): Baulard, A.R. , Blondiaux, N. , Brodin, P. , Christophe, T. , D Prez, B. , Desroses, M. , Flament, M.P. , Flipo, M. , Jeon, H.K. , Lecat-Guillet, N. , Leroux, F. , Locht, C. , Mathys, V. , Piveteau, C. , Siepmann, J. , Soror, S.H. , Villemagne, B. , Villeret, V. , Willand, N. , Wintjens, R. , Wohlkonig, A.